Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reverse Engineering of Digital Measures: Inviting Patients to the Conversation.
Clay I, Peerenboom N, Connors DE, Bourke S, Keogh A, Wac K, Gur-Arie T, Baker J, Bull C, Cereatti A, Cormack F, Eggenspieler D, Foschini L, Ganea R, Groenen PMA, Gusset N, Izmailova E, Kanzler CM, Leyens L, Lyden K, Mueller A, Nam J, Ng WF, Nobbs D, Orfaniotou F, Perumal TM, Piwko W, Ries A, Scotland A, Taptiklis N, Torous J, Vereijken B, Xu S, Baltzer L, Vetter T, Goldhahn J, Hoffmann SC. Clay I, et al. Among authors: leyens l. Digit Biomark. 2023 May 12;7(1):28-44. doi: 10.1159/000530413. eCollection 2023 Jan-Dec. Digit Biomark. 2023. PMID: 37206894 Free PMC article.
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
Le Tourneau C, André F, Helland Å, Mileshkin L, Minnaard W, Schiel A, Taskén K, Thomas DM, Veronese ML, Durán-Pacheco G, Leyens L, Rufibach K, Thomas M, Krämer A. Le Tourneau C, et al. Among authors: leyens l. Eur J Cancer. 2023 Nov;194:113278. doi: 10.1016/j.ejca.2023.113278. Epub 2023 Aug 4. Eur J Cancer. 2023. PMID: 37820553 Free article. Review.
Developing a Novel Measurement of Sleep in Rheumatoid Arthritis: Study Proposal for Approach and Considerations.
Crouthamel M, Mather RJ, Ramachandran S, Bode K, Chatterjee G, Garcia-Gancedo L, Kim J, Alaj R, Wipperman MF, Leyens L, Sillen H, Murphy T, Benecky M, Maggio B, Switzer T. Crouthamel M, et al. Among authors: leyens l. Digit Biomark. 2021 Sep 2;5(3):191-205. doi: 10.1159/000518024. eCollection 2021 Sep-Dec. Digit Biomark. 2021. PMID: 34703974 Free PMC article.
Bridging communities in the field of nanomedicine.
Halamoda-Kenzaoui B, Baconnier S, Bastogne T, Bazile D, Boisseau P, Borchard G, Borgos SE, Calzolai L, Cederbrant K, Di Felice G, Di Francesco T, Dobrovolskaia MA, Gaspar R, Gracia B, Hackley VA, Leyens L, Liptrott N, Park M, Patri A, Roebben G, Roesslein M, Thürmer R, Urbán P, Zuang V, Bremer-Hoffmann S. Halamoda-Kenzaoui B, et al. Among authors: leyens l. Regul Toxicol Pharmacol. 2019 Aug;106:187-196. doi: 10.1016/j.yrtph.2019.04.011. Epub 2019 Apr 30. Regul Toxicol Pharmacol. 2019. PMID: 31051191 Free PMC article.
Personalized Medicine: What's in it for Rare Diseases?
Schee Genannt Halfmann S, Mählmann L, Leyens L, Reumann M, Brand A. Schee Genannt Halfmann S, et al. Among authors: leyens l. Adv Exp Med Biol. 2017;1031:387-404. doi: 10.1007/978-3-319-67144-4_22. Adv Exp Med Biol. 2017. PMID: 29214584 Review.
19 results